Holen Sie sich die Stockscreener-App
99.66
1.83%
-1.86
Handel nachbörslich:
99.66
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt RVTY?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Revvity Inc Aktie (RVTY) Neueste Nachrichten
RVTY Technical Analysis & Stock Price Forecast - Intellectia AI
Revvity Inc. Stock (US76155R1086): valuation focus after quiet trading - AD HOC NEWS
Revvity Inc. stock underperforms Friday when compared to competitors - MarketWatch
Revvity Opera Phenix Plus: high-content screening system in focus for US labs - AD HOC NEWS
Revvity Inc. Stock (US76155R1086): neutral day with the shares in focus - AD HOC NEWS
Revvity Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
What to expect from Revvity's next quarterly earnings report - MSN
Revvity Inc (RVTY) Shares Surge 3.8% -- What GF Score of 78 Tells Investors - GuruFocus
Revvity Inc. stock outperforms competitors on strong trading day - MarketWatch
Revvity stock (US76155R1086): investors eye diagnostics and life science tools story - AD HOC NEWS
Revvity Inc at Goldman Sachs Healthcare Conference Transcript - GuruFocus
Revvity (RVTY) Valuation Check After China Immunodiagnostics Exit Plan And Solid First Quarter Results - Yahoo Finance
Revvity stock edges higher above $99 as technical momentum holds after image of the month post - Traders Union
Revvity, Inc. (RVTY) Stock Analysis: A Compelling 15.53% Upside in the Healthcare Diagnostics Sector - DirectorsTalk Interviews
Dilution adjustment of Revvity, Inc. – XETR:PKN - TradingView
(RVTY) Volatility Zones as Tactical Triggers - Stock Traders Daily
Revvity, Inc. Trade Ideas — XETR:PKN - TradingView
Revvity, Inc. Cash Flow – XETR:PKN - TradingView
Revvity, Inc. Balance Sheet – XETR:PKN - TradingView
Stifel cuts Revvity stock price target on softer valuation - Investing.com
Revvity gains on diagnostics strength, faces China headwinds - MSN
Revvity Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Why is Revvity (RVTY) up 2% since last earnings report? - MSN
Why Is Revvity (RVTY) Up 2% Since Last Earnings Report? - Yahoo Finance
Wolfe Research Initiates Revvity(RVTY.US) With Hold Rating - Moomoo
RVTY Assumed by Wolfe Research -- Rating Set to Peer Perform - GuruFocus
Revvity Inc (RVTY) Stock Down 3.9% -- Now Undervalued? GF Score: 74/100 - GuruFocus
Wolfe Research initiates Revvity stock coverage with Peerperform - Investing.com UK
Wolfe Research initiates Revvity stock coverage with Peerperform By Investing.com - Investing.com Nigeria
Revvity Inc. stock underperforms Monday when compared to competitors - MarketWatch
Why Is S&P 500 Attention on Revvity After Earnings Miss? - Kalkine Media
Research Tools & Consumables Stocks Q1 In Review: Revvity (NYSE:RVTY) Vs Peers - Yahoo Finance
Revvity, Inc. (RVTY) Stock Analysis: A Healthcare Innovator With 8.7% Potential Upside - DirectorsTalk Interviews
RVTY unveils Signals BioDesign for faster molecular cloning & R&D data - MSN
Revvity Inc. stock (US76155R1086): NYSE price holds near 100 USD as technical levels draw focus - AD HOC NEWS
Revvity Inc. stock (US76155R1086): insider activity and recent trading in focus - AD HOC NEWS
Revvity (RVTY) Q1 earnings and revenues top estimates - MSN
A Look at Revvity Inc (RVTY) After 4.6% Gain -- GF Value $120.39 vs Price $101.22 - GuruFocus
Revvity stock (US76155R1086): New share repurchase plan sets tone after recent earnings - AD HOC NEWS
Price-Driven Insight from (RVTY) for Rule-Based Strategy - Stock Traders Daily
RVTY Stock Price and Chart — NYSE:RVTY - TradingView
Revvity stock (US76155R1086): life-science player after recent earnings in focus - AD HOC NEWS
Revvity, Inc. (RVTY) Stock Analysis: A Blend of Healthcare Innovation and Notable Growth Potential - DirectorsTalk Interviews
Revvity stock: Analyst estimates & ratings - MSN
Revvity stock (US76155R1086): cancer test launch and steady demand keep diagnostics group in focus - AD HOC NEWS
Revvity declares $0.07 dividend - MSN
0.38%
0.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):